Inventor · disambiguated record
Matthias Treu
Also filed as: TREU MATTHIAS
15 granted patents·20 pending applications·25 citations·filing 2001–2024
88Inventor score
Files withBOEHRINGER INGELHEIM INT22TREU MATTHIAS5SANOCHEMIA PHARMAZEUTIKA AG2ZAHN STEPHAN KARL2BOEHRINGER INGELHEIM INTL GMBH CORP1
Top patents by PatentIndex Score
35 records- 0188US12065427B2Heterocyclic compounds capable of activating STINGBOEHRINGER INGELHEIM INT·Filed 2022·Granted Aug 20, 2024·1 cites·40 claims
- 0281US8207179B2Substituted indolines as tyrosine kinase inhibitorsENGELHARDT HARALD·Filed 2008·Granted Jun 26, 2012·8 cites·4 claims
- 0377US8546443B2Benzylic oxindole pyrimidinesTREU MATTHIAS·Filed 2011·Granted Oct 1, 2013·5 cites·40 claims
- 0475US10414769B25,8-dimethyl-9-phenyl-5,8-dihydro-6H-pyrazolo[3,4-h]quinazolin-2-yl)-(1H-pyrazol-3-yl)-amines as IGF-1R/IR inhibitorsBOEHRINGER INGELHEIM INT·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 0573US7981880B23-(aminomethyliden) 2-indolinone derivates and their use as cell proliferation inhibitorsBOEHRINGER INGELHEIM INT·Filed 2007·Granted Jul 19, 2011·2 cites·7 claims
- 0672US2025122204A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0771US7714010B2Pyrrolobenzimidazolones and their use as anti-proliferative agentsBOEHRINGER INGELHEIM INT·Filed 2005·Granted May 11, 2010·2 cites·5 claims
- 0871US2024270718A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 0969US9150578B25,8-dihydro-6H-pyrazolo[3,4-h]quinazolines as IGF-1R/IR inhibitorsTREU MATTHIAS·Filed 2013·Granted Oct 6, 2015·2 cites·30 claims
- 1066US2023374021A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1165US2024174642A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1265US2024174641A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1363US7166588B2Derivatives and analogs of galanthamineSANOCHEMIA PHARMAZEUTIKA AG·Filed 2001·Granted Jan 23, 2007·3 cites·14 claims
- 1463US2024166629A1Heterocyclic compounds capable of activating stingBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1562US12060367B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2023·Granted Aug 13, 2024·0 cites·49 claims
- 1662US11608343B2Substituted pyrimido[5,4-d]pyrimidines as HER2 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 21, 2023·0 cites·34 claims
- 1762US2025002504A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1858US11945812B2Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2021·Granted Apr 2, 2024·0 cites·39 claims
- 1956US2023227470A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2054US2010184747A1Indoline derivatives and their use in treating disease-states such as cancerBOEHRINGER INGELHEIM INT·Filed 2008·Application pending·0 cites
- 2154US2025129095A1Annulated 2-amino-3-cyano thiophenes and derivatives for the treatment of cancerBOEHRINGER INGELHEIM INTL GMBH CORP·Filed 2022·Application pending·0 cites
- 2252US2007032514A12,4-diamino-pyrimidines as aurora inhibitorsZAHN STEPHAN K·Filed 2006·Application pending·0 cites
- 2348US2011251174A12,4-diamino-pyrimidines as aurora inhibitorsBOEHRINGER INGELHEIM INT·Filed 2011·Application pending·0 cites
- 2448US2007027138A1Derivatives and analogs of galanthamineSANOCHEMIA PHARMAZEUTIKA AG·Filed 2006·Application pending·0 cites
- 2548US2013281429A12,4-diamino-pyrimidines as aurora inhibitorsZAHN STEPHAN KARL·Filed 2013·Application pending·0 cites
- 2647US11304929B2Tosylacetate based compounds and derivatives thereof as PHGDH inhibitorsBOEHRINGER INGELHEIM INT·Filed 2018·Granted Apr 19, 2022·0 cites·16 claims
- 2747US2010144706A1CompoundsBOEHRINGER INGELHEIM INT·Filed 2007·Application pending·0 cites
- 2846US8853420B2CompoundsTREU MATTHIAS·Filed 2009·Granted Oct 7, 2014·0 cites·15 claims
- 2946US2023126204A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 3046US2023131720A1[1,3]DIAZINO[5,4-d]PYRIMIDINES AS HER2 INHIBITORSBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 3143US2012270859A1Indoline derivatives and their use in treating disease-states such as cancerTREU MATTHIAS·Filed 2012·Application pending·0 cites
- 3242US2007004684A1Alpha-Carbolines as CDK-1 inhibitorsBOEHRINGER INGELHEIM INT·Filed 2006·Application pending·0 cites
- 3340US8623887B2CompoundsZAHN STEPHAN KARL·Filed 2007·Granted Jan 7, 2014·0 cites·15 claims
- 3436US8735386B2AminopyrazoloquinazolinesTREU MATTHIAS·Filed 2011·Granted May 27, 2014·0 cites·42 claims
- 3534US2006069251A1Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereofJORDIS ULRICH·Filed 2003·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthias Treu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →